advertisement
Stewart WC 6
Showing records 1 to 6 | Display all abstracts from Stewart WC20821 Physician attitudes regarding prostaglandin treatment for glaucoma in the United States and Europe
Stewart WC; Stewart JA; Nelson LA; Kruft B
European Journal of Ophthalmology 2008; 18: 199-204
20388 Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide/timolol fixed combination after 2 and 6 months of treatment
Konstas AG; Kozobolis VP; Tsironi S; Makridaki I; Efremova R; Stewart WC
Ophthalmology 2008; 115: 99-103
20321 The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy
Sharpe ED; Reynolds AC; Skuta GL; Jenkins JN; Stewart WC
Current Eye Research 2007; 32: 1037-1043
20644 The use of dorzolamide versus other hypotensive agents to prevent glaucomatous progression
Diafas S; Day DG; Stewart JA; Stewart WC
Therapeutics and Clinical Risk Management 2007; 3: 725-732
20738 Dorzolamide/Timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension
Cvenkel B; Stewart JA; Nelson LA; Stewart WC
Current Eye Research 2008; 33: 163-168
20389 Cost-effectiveness of treating ocular hypertension
Stewart WC; Stewart JA; Nassar QJ; Mychaskiw MA
Ophthalmology 2008; 115: 94-98
